Toxicity of Amyloid-β Peptides Varies Depending on Differentiation Route of SH-SY5Y Cells

Amyloid-beta-dependent phosphorylation of collapsin response mediator protein-2 dissociates kinesin in Alzheimer's disease

(2018) Steven Petratos et al.   Neural Regeneration Research

Common Mechanisms of Alzheimer's Disease and Ischemic Stroke: The Role of Protein Kinase C in the Progression of Age-Related Neurodegeneration

(2018) Brandon P. Lucke-Wold et al.   JOURNAL OF ALZHEIMERS DISEASE

Olive Biophenols Reduces Alzheimer’s Pathology in SH-SY5Y Cells and APPswe Mice

(2018) Syed Omar et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly

(2017) Ersilia De Lorenzi et al.   JOURNAL OF ALZHEIMERS DISEASE

The Neuroprotective Effects of Brazilian Green Propolis on Neurodegenerative Damage in Human Neuronal SH-SY5Y Cells

(2017) Junjun Ni et al.   Oxidative Medicine and Cellular Longevity

In situ fibrillizing amyloid-beta 1-42 induces neurite degeneration and apoptosis of differentiated SH-SY5Y cells

(2017) Jekaterina Krishtal et al.   PLoS One

An In Vitro Model for Neuroscience: Differentiation of SH-SY5Y Cells into Cells with Morphological and Biochemical Characteristics of Mature Neurons

(2017) Lotta Agholme et al.   JOURNAL OF ALZHEIMERS DISEASE

The role of cytosolic phospholipase A2α in amyloid precursor protein induction by amyloid beta1-42: implication for neurodegeneration

(2015) Chen Sagy-Bross et al.   JOURNAL OF NEUROCHEMISTRY

Morphological Differentiation Towards Neuronal Phenotype of SH-SY5Y Neuroblastoma Cells by Estradiol, Retinoic Acid and Cholesterol

(2015) Heidi Teppola et al.   NEUROCHEMICAL RESEARCH

Studying neurodegenerative diseases in culture models

(2014) Johannes C.M. Schlachetzki et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

BDNF and the maturation of posttranscriptional regulatory networks in human SH-SY5Y neuroblast differentiation

(2014) Belinda J. Goldie et al.   Frontiers in Cellular Neuroscience

Therapeutics of Alzheimer's disease: Past, present and future

(2013) R. Anand et al.   NEUROPHARMACOLOGY

Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway

(2013) Brendan D. Looyenga et al.   PLoS One

Proliferation of amyloid- 42 aggregates occurs through a secondary nucleation mechanism

(2013) S. I. A. Cohen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Comprehensive cytogenomic profile of the in vitro neuronal model SH-SY5Y

(2012) Mohammed Yusuf et al.   NEUROGENETICS

Ganglioside-mediated aggregation of amyloid β-proteins (Aβ): comparison between Aβ-(1-42) and Aβ-(1-40)

(2010) Mariko Ogawa et al.   JOURNAL OF NEUROCHEMISTRY

Ganglioside Cluster-mediated Aggregation and Cytotoxicity of Amyloid β-Peptide: Molecular Mechanism and Inhibition

(2010) Katsumi MATSUZAKI   YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

The Recombinant Amyloid-β Peptide Aβ1–42 Aggregates Faster and Is More Neurotoxic than Synthetic Aβ1–42

(2009) Verena H. Finder et al.   JOURNAL OF MOLECULAR BIOLOGY

Dibutyryl cyclic AMP induces differentiation of human neuroblastoma SH-SY5Y cells into a noradrenergic phenotype

(2008) Toshiaki Kume et al.   NEUROSCIENCE LETTERS

Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research

(2008) Yuen-Ting Cheung et al.   NEUROTOXICOLOGY